Sanofi (NASDAQ: SNY) Set to Acquire Provention Bio (NASDAQ: PRVB) for $2.9 Billion
Provention Bio, Inc. (NASDAQ: PRVB) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and ...
Wednesday, March 22, 2023
Tag: Sanofi
Kadmon Holdings, Inc. (NASDAQ: KDMN) Soars After $1.9 Billion Sanofi (NASDAQ: SNY) Takeover Deal
Kadmon Holdings, Inc. (NASDAQ: KDMN) is engaged as a biopharmaceutical company, which is focused on the research, discovery, and development ...
Translate Bio, Inc. (NASDAQ: TBIO) Surges 42% After Expanding Collaboration with Sanofi to Develop mRNA Vaccines for Infectious Diseases
Translate Bio, Inc. (NASDAQ: TBIO) is a clinical-stage mRNA therapeutics company with a focus on development of treatments for diseases ...
How to Play the COVID-19 Vaccine Race
The world has shut down trying to avoid the coronavirus, or COVID-19. Individuals, companies and governments everywhere are getting hit ...
